OTCMKTS:ONPH Oncology Pharma (ONPH) Stock Price, News & Analysis $0.0002 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.00▼$0.000250-Day Range N/A52-Week Range$0.00▼$0.43Volume660 shsAverage Volume6,785 shsMarket Capitalization$7,732.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Oncology Pharma alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Oncology Pharma Stock (OTCMKTS:ONPH)Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.Read More ONPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ONPH Stock News HeadlinesJuly 26 at 11:25 PM | bizjournals.comRx plant spent millions readying cancer drug. Now it can't sell it.July 25 at 5:35 PM | bizjournals.comDay One scores $111 million in licensing deal for child brain cancer drugJuly 27, 2024 | Stansberry Research (Ad)Get out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."May 22, 2024 | bizjournals.comWeston company receives FDA designation for pancreatic cancer drugMay 22, 2024 | benzinga.comGlobal Pharma Giants Are Betting Big On Oncology But Without Daring To Tackle Cancer PreventionMay 18, 2024 | reuters.comEU regulator scraps approval for pregnancy drug over cancer riskMay 16, 2024 | msn.comAmerican Oncology Network GAAP EPS of -$1.22, revenue of $364.34MMay 10, 2024 | msn.comEnding Oncology's Toxic Relationship With High Chemotherapy DosesJuly 27, 2024 | Stansberry Research (Ad)Get out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."May 7, 2024 | msn.comThe FDA targets pharma’s grip on costly, toxic cancer drug dosagesMay 3, 2024 | news.yahoo.comCoach's death spotlights pharma's profit wins in chemo drug shortageMay 2, 2024 | marketwatch.comNovartis to Buy Mariana Oncology for Up to $1.75 Bln in Boost to Radioligand Therapy BusinessApril 30, 2024 | msn.comONO to acquire Deciphera Pharmaceuticals in $2.4B dealApril 30, 2024 | yahoo.comJapan's Ono Pharma says $2.4 billion Deciphera purchase 'first step' for global expansionApril 29, 2024 | benzinga.comWhy Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?April 29, 2024 | msn.comDeciphera stock soars after Ono Pharmaceutical’s $2.4B buyout dealApril 23, 2024 | bizjournals.comPeninsula biopharma wins 1st FDA approval for drug targeting type of brain cancer in kidsApril 17, 2024 | markets.businessinsider.comNika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary SupplementSee More Headlines Receive ONPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today7/26/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Prepackaged software Sub-IndustryComputer Software Current SymbolOTCMKTS:ONPH CUSIPN/A CIKN/A Webwww.oncology-pharma.com Phone(415) 869-1038Fax858-385-8997Employees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares38,660,000Free Float31,704,000Market Cap$7,732.00 OptionableNot Optionable Beta-1.04 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Chuck WagnerPresident, Treasurer & ChairmanMr. George MalesekInterim Chief Executive OfficerMr. Dimitri Theofilopolous Esq.Legal CounselKey Competitors(PVTA)OTCMKTS:PVTA1mage SoftwareOTCMKTS:ISOLAmerica's SuppliersOTCMKTS:AASLAppTech PaymentsNASDAQ:APCXWArogo Capital AcquisitionNASDAQ:AOGOUView All Competitors ONPH Stock Analysis - Frequently Asked Questions How have ONPH shares performed this year? Oncology Pharma's stock was trading at $0.0002 at the beginning of 2024. Since then, ONPH shares have increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2024 here. How do I buy shares of Oncology Pharma? Shares of ONPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ONPH) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research.....The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncology Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONPH Stock Alerts